• Episurf Medical's total issued shares reached 16,280,578,740 as of October 30, 2026.
• The total comprised 473,357 Class A shares and 16,280,105,383 Class B shares.
• Total voting rights stood at 16,281,525,454.
• A directed issue of 40,960,295 Class B shares to Frusipe Intressenter Holding was completed on October 1.
• Convertible conversions added 1,041,561,688 Class B shares on October 1, followed by 206,220,244 Class B shares on October 7.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Episurf Medical AB published the original content used to generate this news brief via Cision (Ref. ID: 20261030:BIT:2348:0) on October 30, 2026, and is solely responsible for the information contained therein.